glp 1 agonist retatrutide PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Retatrutide Triple Agonist Research Peptide
Description
Karakasis P, Patoulias D, Fragakis N, Mantzoros CS
These medications are only available to people with a body mass index (BMI) of 27 or over with at least one weight-related health condition or those with a BMI of 30 or over
A pooled analysis of the incidence rates of acute pancreatitis with the respective drugs and comparators was performed separately for DPP-4 inhibitors and GLP-1 receptor agonists
PLoS ONE 7 , e39656 (2012)
Figure S7
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
[DOI] [PMC free article] [PubMed] [Google Scholar] 190.Balachandra S., Syed R., Song Z., Kasmirski J., Gillis A., Fazendin J., Lindeman B., Chen H
